Financial Management Professionals, Inc.
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1568132
AUSTIN, TX
Position in RXRX
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$5,174
+$846 QoQ
Shares Held
1,410
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 58 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Management Professionals, Inc. holds $87,438 across 14 Biotechnology names. RXRX ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
80 | $39,738 | |
| 2 | ABVX |
Abivax S.A.
|
100 | $13,326 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18 | $11,223 | |
| 4 | CDT |
CDT Equity Inc.
|
10,005 | $5,602 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
1,410 | $5,174 | |
| 6 | INCY |
Incyte Corp
|
36 | $4,080 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
35 | $2,002 | |
| 8 | CAI |
Caris Life Sciences, Inc.
|
96 | $1,710 |
All Filings in RXRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,174 | 1,410 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $4,328 | 1,410 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $5,766 | 1,410 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $6,880 | 1,410 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $7,134 | 1,410 | Shares | Sole | 2025-07-15 | |
| 2024-12-31 | $5,678 | 840 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,535 | 840 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $6,300 | 840 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $8,374 | 840 | Shares | Sole | 2024-04-16 | |
| No filing history on record for this holder in this stock. | ||||||